Back to search
FDAFDA · Food and drugs·Recall number D-0635-2021

maXXzen Platinum 12000 capsule, 1-count blister card (UPC 7 18122 04072 8), Distributed by: Maxx Inc, Los Angeles, CA 90028

Published June 30, 2021 · Recall initiated: May 18, 2021

Summary

FDA records drug Class I recall D-0635-2021, published June 30, 2021 and initiated May 18, 2021. Recalling firm: Miracle 8989; Status: Terminated; Reported quantity: Unknown; Lot: All lots remaining within expiry. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Miracle 8989
Distributor
USA Nationwide
Lot
All lots remaining within expiry.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was maXXzen Platinum 12000 capsule, 1-count blister card (UPC 7 18122 04072 8), Distributed by: Maxx Inc, Los Angeles, CA 90028 recalled?

Yes. FDA published recall D-0635-2021 on June 30, 2021. Reported hazard: Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release